🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07052019
Starting soon Not applicable

Pain Perception and Anxiety With Virtual Reality vs Tell-Show-Do in Children With MIH

NCT07052019 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-01
Last updated
2025-07-04

Condition(s) studied

Molar Incisor Hypomineralization

Investigational drug(s) / intervention(s)

Virtual Reality DistractionTell-Show-Do Technique

Virtual Reality Distraction: Children wear virtual reality glasses during restorative dental treatment to reduce pain and anxiety.

Tell-Show-Do Technique: Conventional behavioral technique where the dentist tells, shows, and then performs the procedure to reduce anxiety and build cooperation.

Study summary

This pilot crossover randomized clinical trial aims to compare the effect of distraction using Virtual Reality (VR) versus the Tell-Show-Do (TSD) technique on pain perception and anxiety in children aged 6-12 with Molar Incisor Hypomineralization (MIH) undergoing restorative dental treatment.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged between 6-12 years. * Patients with two First Permanent molars diagnosed with MIH indicated for class I cavities. * A cooperative and compliant patient/ parent. * Patients not allergic to medicaments necessary to complete the procedure. * Patients with no history of chronic systemic diseases. Exclusion Criteria: * MIH-affected molars require apexogenesis, apexification, regeneration or RCT. * Non-restorable tooth. * Previous restorative treatment. * Periodontally affected. * Children having systemic disease, an emotional behavioural or learning disorder.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
faculty of dentistry, Cairo university Giza Giza Governorate

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07052019 on ClinicalTrials.gov ↗ ← All trials in Egypt